MELC image acquisition

MF Marta Ferreira-Gomes
AK Andrey Kruglov
PD Pawel Durek
FH Frederik Heinrich
CT Caroline Tizian
GH Gitta Anne Heinz
AP Anna Pascual-Reguant
WD Weijie Du
RM Ronja Mothes
CF Chaofan Fan
SF Stefan Frischbutter
KH Katharina Habenicht
LB Lisa Budzinski
JN Justus Ninnemann
PJ Peter K. Jani
GG Gabriela Maria Guerra
KL Katrin Lehmann
MM Mareen Matz
LO Lennard Ostendorf
LH Lukas Heiberger
HC Hyun-Dong Chang
SB Sandy Bauherr
MM Marcus Maurer
GS Günther Schönrich
MR Martin Raftery
TK Tilmann Kallinich
MM Marcus Alexander Mall
SA Stefan Angermair
ST Sascha Treskatsch
TD Thomas Dörner
VC Victor Max Corman
AD Andreas Diefenbach
HV Hans-Dieter Volk
SE Sefer Elezkurtaj
TW Thomas H. Winkler
JD Jun Dong
AH Anja Erika Hauser
HR Helena Radbruch
MW Mario Witkowski
FM Fritz Melchers
AR Andreas Radbruch
MM Mir-Farzin Mashreghi
request Request a Protocol
ask Ask a question
Favorite

We generated the multiplexed histology data on a modified Toponome Image Cycler® MM3 (TIC) originally produced by MelTec GmbH & Co.KG Magdeburg, Germany57,58. The robotic microscopic system consists of: (i) an inverted widefield (epi)fluorescence microscope Leica DM IRE2 equipped with a CMOS camera and a motor-controlled XY-stage, (ii) CAVRO XL3000 Pipette/Diluter (Tecan GmbH, Crailsheim, Germany), and (iii) a software MelTec TIC-Control for controlling microscope and pipetting system and for synchronized image acquisition. The MELC run is a sequence of cycles, each containing the following four steps: (i) incubation of the fluorescence-coupled antibody and subsequent washing; (ii) cross-correlation-based auto-focusing; (iii) photo-bleaching of the fluorophore; and (iv) a second autofocusing step followed by acquisition of a 3D stack post-bleaching fluorescence image. In each four-step cycle another fluorescence-labeled antibody is used. After the sample was labeled sequentially by DAPI (Roche, Cat. No. 10236276001, dilution 1:5000) and all antibodies of interest as described above, the experiment was completed. Fluorescence-coupled antibodies used: IgA2-PE (Clone REA995, Miltenyi, Cat. No. 130-117-763, dilution 1:50); CD27-PE (Clone REA499, Miltenyi, Cat. No. 130-114-166, dilution 1:50); CD38-PE (Clone IB6, Miltenyi, Cat. No. 130-113-427, dilution 1:50); and IgA-PE (Clone IS11-8E10, Miltenyi, Cat. No. 130-114-002, dilution 1:50). The antibodies were stained in the indicated order.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A